• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Metabolic Endocrinology - Type I Diabetes Drug Pipeline Report Product Image

Metabolic Endocrinology - Type I Diabetes Drug Pipeline Report

  • Published: June 2007
  • 12 pages
  • Life Science Analytics

Life Science Analytics, "Metabolic Endocrinology - Type I Diabetes Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of type i diabetes drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.

In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company’s full product pipeline and products by phase of development with regard to the therapy area.

Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of READ MORE >

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Type I Diabetes Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects



--Top Companies in late stage Type I Diabetes Projects
--AutoImmune Inc
--AmCyte Inc.
--BTG plc
--Bayhill Therapeutics, Inc.
--DeveloGen AG
--Chong Kun Dang Pharmaceutical Corp.
--Pharm)
--Diamyd Medical AB
--Diabetology Ltd
--Generex Biotechnology Corporation
--Eli Lilly & Co
--Insmed Incorporated
--GlaxoSmithKline plc
--MacroGenics Inc.
--Living Cell Technologies Ltd
--Osiris Therapeutics Inc
--Novocell, Inc.
--Tolerx, Inc.
--Procter & Gamble Company

--Top Companies in early stage Type I Diabetes Projects
--Alba Therapeutics Corporation
--AdPharma, Inc.
--FIT Biotech Oyj Plc.
--DiaKine Therapeutics, Inc.
--Geron Corporation
--Genzyme Corporation
--Living Cell Technologies Ltd
--Lipoxen
--MultiCell Technologies Inc
--MicroIslet, Inc.
--Oramed Pharmaceuticals Inc
--Novocell, Inc.
--ReNeuron Group plc
--Plantigen Inc.
--Target-In Ltd.
--Schering-Plough Corp

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos